Skip to main content
. 2021 Nov 20;111(4):939–949. doi: 10.1002/cpt.2485

Figure 1.

Figure 1

Study design and patients’ flow. Two hundred eighteen fully compliant patients with ET were included in the analyses of this study. Patients underwent visits for blood collection and biomarker measurements as depicted in the figure. ASA, acetylsalicylic acid; ET, essential thrombocythemia; ITT, intention to treat; NSAIDs, non‐steroidal anti‐inflammatory drugs; TX, thromboxane.